Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
March 28, 2019 Off

 FSD Pharma to Establish Presence in Canada’s Insurance Regimes

By BusinessWire

– Signs agreement focusing on exploring insurance coverage for medical cannabis Canada wide – TORONTO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/FSDDF?src=hash" target="_blank"gt;#FSDDFlt;/agt;–FSD Pharma Inc.…

March 28, 2019 Off

Tricida Announces Positive Results From Long-Term Clinical Trial of TRC101 in Patients With CKD and Metabolic Acidosis

By BusinessWire

Blinded, randomized, placebo-controlled, 40-week extension trial, TRCA-301E, met its primary and all secondary endpoints, supporting the long-term safety and efficacy…

March 28, 2019 Off

Tricida Announces $200 Million Debt Facility With Hercules Capital

By BusinessWire

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its drug…

March 28, 2019 Off

Seattle Genetics to Host Conference Call on Positive Topline Results from Pivotal Trial of Enfortumab Vedotin

By BusinessWire

BOTHELL, Wash.–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq:SGEN) will host a conference call and webcast discussion regarding the positive topline results from…

March 28, 2019 Off

Tricida Announces Fourth Quarter and Full-Year 2018 Financial Results

By BusinessWire

Webcast Today at 8:00 am Eastern Time SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the…

March 28, 2019 Off

Can-Fite Reports 2018 Financial Results & Provides Clinical Update

By BusinessWire

Global distribution deals signed in Europe and China, including Can-Fite’s largest deal to date for up to $74.5 M Top-line…

March 28, 2019 Off

BrainScope Completes Large-Scale Clinical Studies of Concussion in Universities, High Schools and Concussion Clinics

By BusinessWire

Culmination of Four-Year Project With U.S. Department of Defense and NFL-GE Research Funding BETHESDA, Md.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/concussion?src=hash" target="_blank"gt;#concussionlt;/agt;–BrainScope®, a medical…

March 28, 2019 Off

Seattle Genetics and Astellas Announce Positive Topline Results from Pivotal Trial of Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer

By BusinessWire

– Companies Plan to Submit Biologics License Application Later This Year – – Seattle Genetics to Hold Conference Call Today…

March 28, 2019 Off

Polyneuron Raises CHF22.5 Million in Series A to Advance Novel Therapies for Autoimmune Diseases

By BusinessWire

Leading venture capital firm Sofinnova Partners led the Series A financing, together with New Enterprise Associates, which co-led the round…

March 27, 2019 Off

Tricida to Report Long-Term Clinical Trial Results for TRC101 in CKD Patients with Metabolic Acidosis and Host Conference Call and Webcast on Thursday, March 28, 2019

By BusinessWire

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tricida, Inc. (Nasdaq: TCDA) today announced that it will report results from its blinded, 40-week extension trial,…

Posts pagination

Previous 1 … 3,324 3,325 3,326 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine